Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 12,130
-730 (-5.68%)
At close: Oct 12, 2026
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 727.85 billion as of October 12, 2026. It is the 13,849th most valuable company in the world and the 352nd biggest in South Korea. Its market cap has decreased by 3.81% in one year.
Market Cap
727.85B
Enterprise Value
n/a
Revenue
23.94B
Global Rank
Country Rank
#352 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 727.85B, an increase of 1,676.98%. That is a compound annual growth rate of 9.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 727.85B | -16.52% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.36T |
| Komipharm International | 821.80B |
| Chabiotech | 758.52B |
| Onconic Therapeutics | 675.21B |
| Hyundai Bioscience | 668.77B |
| GI Innovation | 545.81B |
| AbClon | 509.78B |
| Proteina | 489.96B |